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Methods: 581 subjects (49.7% males), a random sample of the gen- 
eral Olmsted County population aged 45 y and above, underwent trans. 
esophageal echocardlogrephy (TEE) with color.Dopplar Imaging and con- 
trast Injection, as part of the Stroke Prevention: Assessment of Risk In a 
Community (SPARC) study, The echocardlographlc finding of PFO was com- 
pared between SPARC subjects end patients undergoing TEE at the Mayo 
Cllfllo duflng the same time period, for various clinical Indications: e) Search 
of a source of cerebral embolism (Stroke group, n ,= 1259); b) Other mlscel. 
laneous, non.embollo indications (MIte, group, n .  R203), 
Re~l#ts: The proportions (%) of subjects with PFO (number of subjects In 
each G'oup In parenthesis) ere presented In the table: 
8P^RO ~,o (14o) 20,3 (1~6) ~e3 (11~) P.1,1 (osl ~a,o (77) 
8stoke 22,0 t169) 17,7 (27~) ~0,4 (400) 19,9 (317) 11,8(~1) 
Age end gender-adjusted odds ratios of PFO were 0,71 (96% confidence 
Interval 0,66-.0,89)/or the Stroke group and 030 (0,24-0,38) for the Mist, 
group, compared to the SPARC cohort, 
Concqos/one: The frequency of PFO wee surprisingly higher in the general 
pepulattP~ (~PARC) th~n In the Stroke group, possibly relating to s more 
Wsfometio search for PFO in 8PARC, a stroke.oriented stu~, Similarly, the 
relatively low fmquenoy of PFO in the non.stroke (Mlso,) group may be due to 
t~ lass meticulous seemh for PFO In ~ta not evaluated for stroke, The results 
el our study question the role of PFO as a risk factor for cerebral ompoltsm, 
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~ Increased Left Atrial Size Risk Fa©ter for as a 
lachaml¢ Stroke in a Multlethnl© Populat ion 
M,R, DI Tullio, R,L, Saeco, R,R, Solaces, B, Boden-AIbala, D,R, ewes, 
A,K, Fard, I, TIfove, L,M, Mondoza, S, Hommo, Columbia Universi~ New 
York, NY, USA 
~mun(t :  Left atrial enlargement (LAE) has been shown to be associated 
with Ischamlc slreke (IS), but only In predemlnantly white populations, The 
risk of IS associated with LAE In non.while subjects is therefore unastab- 
Iished, 
M~thods: Aa a part of the Nollhom Monhattan Stroke Study, we performed 
transthomclc echocordtography In 433 patients with acute IS (200 F, 233 
M, moan age 68,9 ~ 12,3 yaars) and in 451 community control subjects 
matched for age, gender end race-ethniclty. LA antere-posterior diameter 
was mea,~urad and Indexed by body surtece area. Odds ratio (OR) with 95% 
confidence intervals (Ct) for increasing LA size and IS were calculated in 
the overall group and by race.ethnic subgroups using conditional ogistic 
regression, 
Resettle: LAE was associated with IS in the overall group (OR 2.0 for 
each 10 mm increase in LA index; CI 1,5-2,5). The risk of IS was similar in 
whites (OR 29, CI 1.2-3,,~), blacks (OR 1,6, CI 1,02-2,4) and Htspanics (OR 
2,3, CI 1,6...,3.4), The association betwmJn LAE and IS was independent of 
arterial hypertension, diabetes mellltus, cigarette smoking, atdal fibrillation, 
coronary artery disease and echocardlographlcalty determined left ventricular 
hypertrophy In tha overall group (adjusted OR 1.5, CI 1.2-2,0) and in all 
race-ethnic subgroups (adjusted ORs ranging from 1.5 to 1,6), 
Conc/us/ons: 1) LAE is an independent risk factor for IS. 2) The increase 
in risk IS similar across various rece-ethntc subgroups. 
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~"~- I  Atrial Fibril lation Is Associated With a 
Thrombophl l lc  State - The Chin-Shah Community 
Cardiovascular Cohort  Study 
T..D. Wang, C.-C, Wu, K,-L, Chloe, C,.M, Lee, W.-J, Chen, M,-F, Chen, 
C.-S, Lieu, Y.-T. Lee, National Taiwan University Hospital, Ta~pei, Paiwan 
Background: The precise mechanisms of increased thremboembolic risk in 
patients with atrial fibrillation (AF) have not been tully elucidated, though em- 
bolism of thrombi from the left atrium has been thought o be the main patho- 
genetic mechanism. The purpose of this study was to determine whether AF 
is associated with ebnormal',lms inplasma fibrino-coagulaion factors indica- 
tive of a prethrembotic state, which might in part account for the increased 
thmmboembolic risk in AF. 
Methods: In an attempt to conduct an investigation of cardiovascular 
disease in Taiwan, a prospective, population-based study entitled "Chin-Shan 
Community Cardiovascular Cohort Study" was begun in 1990 with e cohort 
of 3,602 people aged ~36 years old, A total of 2,598 participants have 
been biennially followed up for 4 years, in whom there were 35 subjects 
having AF, with a prevalence of 1.4%. Four fibrino-coagulation markers: 
fibrinogen, factor VIII coagulant activity, tissue plasminogen activator (tPA), 
and plasmlnogen activator Inhibitor 1 (PAl-I), from peripheral venous blood 
were carefully evaluated in these participants, 
Results: By unlvarlste analysis, the plasma levels of factor VIII activity 
and SPA in petlents with AF were significantly higher than those In non-AF 
participants (factor VIII, 175,9 ± 54,8 ve 144,1 ± 62,8% [mean ± SOl, p 
< 0,01; tPA, 11,8 ± 5,2 ve 8,9 ± 4,6 ng/ml, p < 0,01; respe~lvely). The 
differences In plasma flbdnogen and PAl-1 levels between AF and non.AF 
subjects were not statistically significant, Mulllvedate analysis ahow~:l that 
AF was independently associated with an Increased plasma SPA level (p < 
0,008) but not factor Viii activity, Them were 11o elgnlf¢an! differefl~s in 
plae,'na flbdnogan, factor VIII, SPA, and PAt,1 levels between patlenfo with 
chemic and paroxysmal AF, 
Gonoluslon: This study has shown that plasma SPA levels were increst~4~d 
in patients wllh AF, This result sugges~ that a thrembophi!i¢ slat@ may 
contflbufo to the increased ltsk of thromlxmmbo!lsm in pabente with AF, 
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9~'0-- -~ Coronary Revas©ularLzetion ! l  Unde~ut i l~  in / /  
Medicaid Patlenta With A©ute I~ard la l  Infarct ion 
L,R, Goldberg, G,W, DeQ, T.G OiSalvo, E,F. Phill~n. &Cassachuseffs 
Geneme Ho~o~al, ~ton ,  MA, USA 
Background: Treatment biases have been reported in the management el 
myocardial infarCtion (MI), 
Methods: Using the comprehensive NY State Department of Health ho~ 
tal administrative data sat (SPARCS), we identified all patients (pts) admitted 
with MI in NY State in 1995, Clinical data, procedure rates and hospital mo~- 
tallty were compared between Medicaid (N = 2584), HMO (N = 2814) and 
Indemnity insurance pte (N = 8215). 
Results: Medicaid pts, older and more likely female, had a higher incJ- 
dance of diabetes (35.5 ve 22 vs 22%), CHF (32.2 vs 18.3 vs 19%) and 
a higher comorbidity index (table), Despite these high-ask charactenst~s, 
Medicaid pts underwent fewer invastve diagnostic and revasculanzatton pro- 
cedures and their mortality was nearly 2 fold greater. 
Med=ca~ HMO Inderrm~ 
Age (Ye&rs) t 59 4 i 12 9 55.8 ~ 10.5 567 ± 10 0 
Female GendeT 1 46.4% 26 2% 254% 
Comort, dlty Index t 24 ± 1.6 1.8 * I 2 1 8 ± 1 2 
Cat heteP,,zatTon t 34,2% 504% 401% 
Revasculanzatmnt 142% 26.0% 189% 
MortaMy r 8.1% 43% 3 9% 
I = p ¢ 0.05 for comparisons across 8113 groups 
Conclusions: 1) Medicaid pte with MI have a higher in-hospital mortality 
than HMO or Indemnity pte. 2) Coronary angiography and revasculenzation 
are under utilized in higher-risk Medicaid pts. The effect el patient character- 
istics or treatment bias on this observed mortality difference deserves further 
study. 
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~-00- -~ Geographic Treatment of  Acute Variat ion in 
Myocardial Interctl~n: Results From the HCFA 
Cooperat ive Cardiovascular  Project 
G,T, O'ConnOro H. Qu;nton, N.D, Tmven, T,A. Oodds, J.E. Wennberg. 
Dartmouth Medical School, Hanover` NH: Northeast Health Cam Quality 
Foundation, Dover, NH, USA 
Background: Clinical consensus on the treatment of acute myocardial infarc- 
tion (AMI) has led to the development of quality indicators for pharmacologic 
therapy, thrembolysis, and smoking advice. The purpose of these analyses 
was to study geographic variation in the correspondence between these 
indicetc s and the clin:,~:al care provided, 
Methods: The zip codes of Medicare beneficiaries were used to create 
3,436 empirically derived Hospital Service Areas (HSA) which were further 
classified into 306 Hospital Referral Regions (HRR) each containing the 
hospital(s) providing cardiac surgery and other tertiary care services to an 
aggregation of HSAs. Data from the Cooperative Cardiovascular Project 
were mapped to these areas. This analysis data set contained records 
of 224,377 patients treated for AMI; 194,927 [86.9%] were confirmed by 
clinical, laboratory and/or EKG criteria. Analyses for quality indicators related 
